Most recently, Bambusa Therapeutics raised $40.0M in its Early Stage VC (Series A2) (Oct 2025).
- ·The complete investor list: 11 names
- ·Watch Bambusa Therapeutics: the Monday email on marks, rounds and moves
Bambusa Therapeutics round by round
4 roundsHow much has Bambusa Therapeutics raised?
Bambusa Therapeutics has raised $143 million across 4 recorded rounds since 2024. The largest was a $9 million early-stage round in Jun 2024; the most recent was a $40 million Series A2 in Oct 2025.
Bambusa Therapeutics has filed 3 Form Ds with the SEC, most recently in Feb 2025 ($53.3 million sold to 16 investors).
Bambusa Therapeutics investors
11 investors are on record for Bambusa Therapeutics, including RA Capital Management, The Invus Group, INCE Capital and Redmile Group. The Series A2 in Oct 2025 drew 9 investors.
11 investors have backed Bambusa Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Bambusa Therapeutics
- How much has Bambusa Therapeutics raised?
- Bambusa Therapeutics has raised $143.0M in total across 4 recorded funding rounds.
- When was Bambusa Therapeutics's last funding round?
- Bambusa Therapeutics's most recent recorded round was Early Stage VC (Series A2) in Oct 2025, raising $40.0M.